Fortress Biotech CFO granted 400,000 RSUs
Jin David reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Jin David reported acquisition or exercise transactions in this Form 4 filing.
Fortress Biotech, Inc. Chief Financial Officer Jin David reported receiving an equity compensation grant of 400,000 restricted stock units, each representing one share of common stock. The units vest in four equal annual installments, with the first vesting on January 5, 2027, contingent on his continued service.
After this award, his reported holdings total 1,651,571 shares of common stock, including 1,230,000 shares underlying previously granted deferred restricted stock units. The transaction reflects a grant or award, not an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 400,000 shares
Grant/Award
1 txn
Insider
Jin David
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 400,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock, par value $0.001 — 1,651,571 shares (Direct)
Footnotes (2)
- F1. Represents an award of 400,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments, with the first installment vesting on January 5, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Vested restricted stock units will be settled in shares of the Issuer's common stock.
- F2. Total holdings include 1,230,000 shares underlying previously granted deferred restricted stock units.
Key Figures
RSU grant size: 400,000 restricted stock units
Total holdings after transaction: 1,651,571 shares
Deferred RSU underlying shares: 1,230,000 shares
+2 more
5 metrics
RSU grant size
400,000 restricted stock units
Award to CFO Jin David reported on Form 4
Total holdings after transaction
1,651,571 shares
Common stock held after RSU award
Deferred RSU underlying shares
1,230,000 shares
Shares underlying previously granted deferred restricted stock units
Vesting schedule length
4 annual installments
RSUs vest in four equal yearly tranches
First vesting date
January 5, 2027
Initial vesting date for the RSU award
Key Terms
restricted stock units, deferred restricted stock units, vesting
3 terms
restricted stock units financial
"Represents an award of 400,000 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred restricted stock units financial
"Total holdings include 1,230,000 shares underlying previously granted deferred restricted stock units."
Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.
vesting financial
"The restricted stock units vest in four equal annual installments, with the first installment vesting on January 5, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Fortress Biotech (FBIO) report for CFO Jin David?
Fortress Biotech reported that CFO Jin David received a grant of 400,000 restricted stock units. Each unit represents one share of common stock as equity compensation, increasing his total reported holdings to 1,651,571 shares, including previously granted deferred restricted stock units.
How many restricted stock units did the Fortress Biotech (FBIO) CFO receive?
The CFO received an award of 400,000 restricted stock units from Fortress Biotech. Each restricted stock unit represents a contingent right to receive one share of common stock, subject to vesting conditions and his continued service with the company over several years.
What is the vesting schedule for Jin David’s Fortress Biotech (FBIO) RSU grant?
The 400,000 restricted stock units vest in four equal annual installments starting January 5, 2027. Each year one quarter of the units vests, provided Jin David continues serving the company through each applicable vesting date before settlement in common shares.
What are Jin David’s total reported Fortress Biotech (FBIO) holdings after this grant?
After the award, Jin David’s total reported holdings are 1,651,571 shares of common stock. This figure includes 1,230,000 shares underlying previously granted deferred restricted stock units, in addition to the newly awarded 400,000 restricted stock units.
How are the Fortress Biotech (FBIO) restricted stock units for the CFO settled?
Vested restricted stock units for the CFO will be settled in shares of Fortress Biotech common stock. Each unit converts into one share once the applicable annual vesting condition is met and his continued service requirement through the vesting date is satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
